Despite the many advances that have occurred in the field of vaccine adjuvants, there are
still unmet needs that may enable the development of vaccines suitable for more …

Liposomes are widely utilized as a carrier to improve therapeutic efficacy of agents thanks to
their merits of high loading capacity, targeting delivery, reliable protection of agents, good …

Liposome as a revolutionizing carrier, has exhibited favorable aspects in drug delivery.
However, there are numerous challenges affecting its effectiveness. Hypersensitivity …

Liposomes are safe, biocompatible, and biodegradable spherical nanosized vesicles
produced from cholesterol and phospholipids. Recently, liposomes have been widely …

Introduction Liposomes have been used as carriers for vaccine adjuvants and antigens due
to their inherent biocompatibility and versatility as delivery vehicles. Two vial admixture of …

Mucus is a viscoelastic gel that acts as a protective barrier for epithelial surfaces. The
mucosal vehicles and adjuvants need to pass through the mucus layer to make drugs and …

Background and aims Proprotein convertase subtilisin kexin type 9 (PCSK9) is a liver
secretory enzyme that controls plasma low-density lipoprotein cholesterol (LDL-C) levels …

Nanovaccines constitute an innovative approach in vaccinology, enabled by the
nanotechnology advances on the synthesis, functionalization and application of …

We developed a SARS-CoV-2 spike subunit vaccine formulation containing dual TLR ligand
liposome adjuvant. The vaccine-induced robust systemic neutralizing antibodies and …

To increase vaccine immunogenicity, modern vaccines incorporate adjuvants, which serve
to enhance immune cross-protection, improve humoral and cell-mediated immunity, and …